Introduction {#section6-1759720X20930493}
============

Fibromyalgia (FM) is a syndrome of unknown aetiology characterized by chronic, diffuse and generalized pain^[@bibr1-1759720X20930493]^ that directly affects the quality of life of those affected.^[@bibr2-1759720X20930493]^ Furthermore, FM patients have a decreased cardiorespiratory capacity compared with age-matched sedentary healthy subjects,^[@bibr3-1759720X20930493]^ vegetative disorders (mainly asthenia) and alteration of biological rhythms, which alter rest-activity circadian rhythms.^[@bibr4-1759720X20930493]^

These factors cause constant fatigue and insufficient muscle tissue repair, with increased pain, in individuals with FM.^[@bibr5-1759720X20930493]^ All this predisposes to disability and reduced physical functionality.^[@bibr6-1759720X20930493][@bibr7-1759720X20930493]--[@bibr8-1759720X20930493]^ In addition, previous studies have shown a decrease of motor cortex (M1) excitability in FM patients,^[@bibr9-1759720X20930493],[@bibr10-1759720X20930493]^ which may be due to hypoexcitability of the corticospinal tract,^[@bibr10-1759720X20930493]^ and in turn, related to motor control dysfunction, causing inappropriate and fatiguing movement patterns.^[@bibr11-1759720X20930493]^

As a multisystem disorder with various concomitant symptoms, FM is approached from a multidisciplinary perspective. Pharmacological therapy is usually the main treatment,^[@bibr5-1759720X20930493]^ but given its chronicity, non-pharmacological approaches are needed to improve signs and symptoms. Some of the non-pharmacological therapies used include cognitive-behavioural therapy, such as patient education or relaxation techniques^[@bibr12-1759720X20930493]^ as well as nutrition education.^[@bibr13-1759720X20930493]^ However, the most commonly used non-pharmacological treatment is physical exercise, particularly low-intensity physical exercise,^[@bibr14-1759720X20930493]^ which has been shown to reduce perceived pain by improving the general physical condition, resulting in decreased fatigue and increased quality of life.^[@bibr15-1759720X20930493][@bibr16-1759720X20930493]--[@bibr17-1759720X20930493]^

However, prior investigations have shown poor-quality evidence on the reduction of pain intensity and improvement of physical function in FM.^[@bibr14-1759720X20930493]^ Further, the wide-spread pain experienced by people with FM usually hinders physical effort and, therefore, the adherence to this type of intervention may be jeopardized.^[@bibr18-1759720X20930493]^ Based on the foregoing, therapies need to be readdressed to include other pain and fatigue treatments not involving physical effort. In this regard, applying a therapy that focuses on improving tissue oxygenation, such as hyperbaric oxygen therapy (HBOT), may improve generalized fatigue,^[@bibr19-1759720X20930493]^ which could, in turn, reduce pain.

This therapy has been previously studied in other populations as an effective strategy to reduce fatigue which has been attributed to increased tissue oxygenation.^[@bibr20-1759720X20930493],[@bibr21-1759720X20930493]^ Five studies that have evaluated the effects of HBOT in FM patients^[@bibr22-1759720X20930493][@bibr23-1759720X20930493][@bibr24-1759720X20930493][@bibr25-1759720X20930493]--[@bibr26-1759720X20930493]^ reported improved quality of life,^[@bibr22-1759720X20930493][@bibr23-1759720X20930493]--[@bibr24-1759720X20930493],[@bibr26-1759720X20930493]^ reduced number of tender points and increased pressure pain threshold,^[@bibr23-1759720X20930493],[@bibr26-1759720X20930493]^ as well as neuroplasticity induction and neuromuscular efficiency.^[@bibr23-1759720X20930493],[@bibr25-1759720X20930493]^ However, high-pressure hyperbaric chambers were used in all these cases, between 2 and 2.5 atmospheres absolute (ATA), involving side effects, such as middle ear or sinus/paranasal barotrauma, or prodromal symptoms of central nervous system toxicity (the latter appearing in less than 50% of cases).^[@bibr27-1759720X20930493][@bibr28-1759720X20930493]--[@bibr29-1759720X20930493]^ For this reason, new protocols using lower pressure (e.g. 1.45 ATA) should be tested.

In addition, until now, the impact of HBOT has only been compared against a placebo treatment^[@bibr26-1759720X20930493]^ or with groups that have not performed any type of treatment,^[@bibr23-1759720X20930493],[@bibr24-1759720X20930493]^ but no study has compared this type of intervention with physical exercise, which, as discussed, is the most commonly used treatment.

The main purpose of this study is to analyse the effect of low-pressure HBOT on induced fatigue, pain and endurance, and functional capacity when compared with those obtained from a physical exercise program in women with FM. Further, we aim to explore the impact of such therapy on physical performance and cortical excitability.

Methods {#section7-1759720X20930493}
=======

Participants {#section8-1759720X20930493}
------------

A total of 49 women diagnosed with FM participated in this study. They were recruited from several fibromyalgia associations over a 4-month period (September 2017 to January 2018). The inclusion criteria were: women aged 30--70 years and diagnosed by a rheumatologist according to the 2016 American College of Rheumatology \[i.e. they should meet the following criteria: generalized pain for at least 3 months and a widespread pain index (WPI) ⩾7 and symptom severity scale (SSS) ⩾ 5 or a WPI of 4--6 and a SSS score ⩾ 9\].^[@bibr30-1759720X20930493]^ Further, they should have followed pharmacological treatment for more than 3 months without clinical improvements and have the capacity to sign the informed consent form accordingly.

Exclusion criteria were: pregnancy or breastfeeding; presence of other advanced-stage pathologies associated with the locomotor system that make physical activity impossible (arthritis, osteoarthritis, uric acid); tympanic perforations; epilepsy; drugs that lower the convulsive threshold; history of intense headaches; endocranial and hearing implants; non-fibromyalgia-related pathology affecting the nervous system, either central or peripheral; endocranial hypertension; uncontrolled arterial hypertension; heart and/or respiratory failure; cardiac pacemaker; pneumothorax; claustrophobia and/or psychiatric pathologies; neoplasia and surgical interventions in the last 4 months. Further, patients with addiction problems related to alcohol, psychoactive drugs or narcotics were excluded. Moreover, patients should never have received previous treatment with a hyperbaric chamber, and they should not have been enrolled in any physical exercise program 2 months before the study began. All these issues were evaluated with a careful anamnesis and the information was further supervised by medical specialists when necessary. Participants who failed to accomplish the inclusion criteria or met any exclusion criteria was excluded from the study.

Study design {#section9-1759720X20930493}
------------

A randomized controlled trial was carried out (within a broader project \[[ClinicalTrials.gov](http://ClinicalTrials.gov) identifier: NCT03801109\]). The participants were randomly allocated to three different groups using simple randomization with Random Allocation Software^[@bibr31-1759720X20930493]^ by an external assistant who was blinded to the study objectives: physical exercise group (PEG) (*n* = 16), hyperbaric oxygen therapy group (HBG) (*n* = 17) and control group (CG) (*n* = 16). To analyse the effect of the interventions, two assessments were carried out: one at baseline, before treatment (T0) and another upon completion (T1). To reduce bias, both the physical therapist who performed the assessments and the statistician were unaware of group allocation.

All participants provided written informed consent, while all procedures were conducted in accordance with the principles of the World Medical Association Declaration of Helsinki and the protocols were approved independently by the Ethics Committee of the Universitat de València (H1548771544856).

Sample size calculation {#section10-1759720X20930493}
-----------------------

Sample size was calculated taking into consideration the three study groups measured twice and expecting a medium effect size (*d* = 0.5). Further, a type I error of 5% and a type II error of 20% were set. The result of this calculation amounted to 42 volunteers (14 in each group). Ultimately, 49 women were included to prevent loss of power due to possible dropouts. G-Power^®^ version 3.1., was used for sample size estimation (Institute for Experimental Psychology, University of Düsseldorf, Düsseldorf, Germany).

Intervention procedures {#section11-1759720X20930493}
-----------------------

As reported, the participants were allocated to three different interventions as further discussed below. The treatments were applied by two physiotherapists with more than 4 years' experience in these techniques. Participants were not receiving any other rehabilitation or pain treatment intervention as part of the study protocol.

### Low-pressure hyperbaric oxygen treatment {#section12-1759720X20930493}

The participants of this group received low-pressure hyperbaric oxygen treatment, consisting of a total of 40, 90-minute sessions, with five sessions per week. For the prevention of anxiety and irritability,^[@bibr32-1759720X20930493]^ 100% oxygen with air breaks at 1.45 ATA, was used. Oxygen purity at 97% was applied with a mask to the participants inside the hyperbaric chamber. In addition, an anti-panic button was available. The hyperbaric chamber used was Revitalair^®^ 430 (Biobarica, Buenos Aires, Argentina). Every day participants recorded their level of pain according to visual analogue scale (VAS) before and after each session. The session ended if patients reported intense headache or earache or severe muscle soreness (i.e. ⩾7.5 on VAS).^[@bibr33-1759720X20930493]^

### Low-intensity physical exercise {#section13-1759720X20930493}

Participants of this group were enrolled in a low-intensity physical exercise program using the following protocol: 16 sessions in all, two sessions a week, 60 min each. Exercises were divided into three parts: a 10-minute warm-up, 40 min training and 10 min cool-down. Training included following a combined endurance and coordination protocol based on a previous study from our group.^[@bibr16-1759720X20930493]^ The objectives of physical exercise were: to reduce fatigue, reduce pain, improve endurance and aerobic capacity for which the volume and intensity of work was defined and controlling heart rate (HR) based on the exertion perceived and the number of repetitions.

In order to achieve the objectives, 16 progressive sessions were designed, the first four sessions being devoted to adjusting participants to the exercise in a progressive way. This first phase included walking for 15 min at a comfortable speed, and completion of a set of 10 exercises for 25 min, performing 10 repetitions of each one.

In the first session, as a familiarization phase, participants started by using 1-kg dumbbells and ballast weights to conduct the exercises at a velocity determined by a metronome set at 60 beats per minute. With this load and velocity, participants performed all the exercises and the perceived exertion was subsequently registered. To ensure that the perceived effort was weak or very weak (i.e. 1--2 categories in the Borg CR-10),^[@bibr34-1759720X20930493]^ the load was adjusted for the next two sessions. In the fourth session, the load was again modified to ensure a moderate effort (i.e. 3--4 categories in the Borg CR-10) for the rest of the sessions.

In the second phase (5th--16th session) the exercise circuit was performed for 40 min. For each exercise, participants had to perform as many repetitions as possible in 1 min. The number of repetitions and load varied depending on the participant, as they were allowed to adapt the exercise according to their pain and perceived exertion each day; however, repetitions were always in the range of 15--25, which meets the health recommendations of physical exercise according to the 2014 Guide for the prescription of physical exercise of American College of Sport Medicine for endurance training.^[@bibr35-1759720X20930493]^

The exercises for combined training were designed to target endurance and coordination. Endurance training focused on the strengthening of upper and lower limbs using dumbbells/weights with a load of 0.5--2 kg for the upper limbs and 1--3 kg for the lower limbs. Soft elastic bands were also used for limb and trunk training, which involve a resistance of 13 N when the band is stretched to double its length (100% deformation).^[@bibr36-1759720X20930493]^ Coordination and flexibility exercises included flexing heels up and down, sitting down and getting up from a chair, stepping up and down and throwing a ball into the air and catching it. In this intervention, participants also recorded their level of pain according to VAS before and after each session. The session ended if patients reported severe pain (i.e. ⩾7.5 on VAS).^[@bibr33-1759720X20930493]^

### Control group {#section14-1759720X20930493}

Participants assigned to this group received no kind of therapy and were asked to perform their usual routines, that is, to continue with their usual medication, without increasing or lowering the dose (as in all other groups) and if they did any physical activity, they should also continue with this without increasing or reducing it. The time from the first evaluation to the re-evaluation was also 8 weeks, equivalent to the period used in PEG and HBG. Upon study conclusion, the participants of this group were offered to choose one of the previous treatments (according to their preference).

Assessments {#section15-1759720X20930493}
-----------

All assessments were conducted twice, once before the intervention and another after the intervention (in the following week).

### Induced fatigue {#section16-1759720X20930493}

Fatigue following the completion of the 6-minute walking test (6MWT) test was measured using the CR-10 Borg scale, which has been shown to be valid and reliable in women with FM.^[@bibr37-1759720X20930493]^ Participants should specify their sensation of fatigue after walking for 6 min.^[@bibr38-1759720X20930493]^

### Pain {#section17-1759720X20930493}

The intensity of perceived pain at rest was measured using a 100-mm VAS, whose reliability and validity has been previously reported for chronic pain.^[@bibr39-1759720X20930493]^ The VAS consisted of a continuous line between two endpoints, with 0 being no pain and 100 being maximum tolerable pain.

### Pressure pain threshold {#section18-1759720X20930493}

We assessed the pressure pain threshold (PPT) in each of the 18 tender points formerly used to diagnose FM. We used an algometer (WAGNER Force Dial TM FDK 20/FDN 100 Series Push Pull Force Gage, Greenwich CT, USA) to assess the PPT (i.e. the smallest stimulus causing the sensation of pain) of the soft tissues located bilaterally at occiput, lower cervical muscles, trapezius, supraspinatus, second ribs, lateral epicondyle, gluteal muscles, greater trochanter and knees. The presence and location of the tender points was first confirmed *via* palpation and was pen-marked by an experienced physiotherapist. The pressure threshold was then measured by applying the algometer directly to the tender point, with the axis of the shaft at 90° relative to the explored surface. The algometer tip was 1 cm^2^ and the pressure values were reported in kg/cm^2^. The subject was instructed to verbally report any feeling of pain or discomfort as soon as this started. The procedure used has excellent intra-observer reliability.^[@bibr40-1759720X20930493]^

Since in the preliminary exploratory analyses of data (repeated measures *t*-Test) no differences between hemibodies were found, the average pressure pain threshold of the two sides was provided for subsequent analyses.

### Endurance and functional capacity {#section19-1759720X20930493}

The 6MWT was used to assess walking endurance and functional capacity. Participants walked 15 meters along a hallway for a total of 6 min.^[@bibr41-1759720X20930493]^ Before starting, patients sat in a chair located near the starting line. Any previous contraindications were checked before the test started, thus recording HR, oxygen level and Borg rate of perceived fatigue in addition to the main variable, namely, the walked distance.

Patients were allowed to take as many standing rests as they liked, but the timer kept going. The instructions given to the patients were: 'Walk to the turnaround point at each end. I am going to use this counter to keep track of the laps you complete. You may stand and rest, but resume walking as soon as you are able. Remember the aim is to walk as far as possible, but do not run or jog'. The test-retest reliability has been proved as excellent.^[@bibr42-1759720X20930493]^

### Physical performance {#section20-1759720X20930493}

The Short Physical Performance Battery (SPPB) was carried out to assess physical performance. The SPPB consists of three subtests: a hierarchical test of balance, a short walk at usual pace and standing up from a chair five times consecutively. Performance of the balance test required holding 3 positions: feet together, semi-tandem and tandem for 10 s each. For the walking test, the participant walked a distance of 4 meters at their usual pace. Finally, in the getting-up and sitting-down in a chair test, the participant would stand and sit 5 times, as quickly as possible, and the total time used was recorded. Each test scores from 0 (worst performance) to 4 (best performance). In addition, a total score is obtained for the entire set, which is the sum of the three tests and ranges from 0 to 12.^[@bibr43-1759720X20930493]^

### Cortical excitability {#section21-1759720X20930493}

Brain excitability was measured by recording the resting motor threshold (RMT), by surface electromyography using Neuro-MEP-Micro integrated in a Neuro-MS/D transcranial magnetic stimulator (Neurosoft^®^, Ivanovo, Russia). The RMT is defined as the minimum signal strength that must be provided for an evoked motor potential of at least 50 microvolts in 50% of the tests.^[@bibr9-1759720X20930493],[@bibr44-1759720X20930493]^ To determine the RMT, TMS_MTAT_2.0.1 software was used, which based on an algorithm allowed to set the number of repetitions needed and to select those where at least 50 mV were obtained, in the first dorsal interosseous of the right hand. To obtain this, a single-pulse left hemisphere stimulation was performed using the Neuro-MS/D magnetic stimulator with a figure-of-eight-shaped coil. The coil was placed at the motor cortex M1, at a 45° angle with respect to the midline.

Statistics {#section22-1759720X20930493}
----------

All statistical analyses were performed with SPSS v.24 (IBM SPSS, Inc., Chicago, IL, USA). Standard statistical methods were used to obtain the mean and standard deviation (SD). Inferential analyses of the data were performed using two-way mixed multivariate analysis of variance (MANOVA), with an inter-subject factor called 'group' with three categories (PEG, HBG and CG) and a within-subject factor called 'treatment' with two categories (T0 and T1). *Post hoc* analysis was conducted using the Bonferroni correction provided by the statistics package used, and the effect size was calculated using Cohen's d. We also compared the age and the level of pain experienced between groups using a one-way MANOVA to ensure that the groups were similar at baseline. Type I error was established as \<5% (*p* \< 0.05).

Results {#section23-1759720X20930493}
=======

Participants {#section24-1759720X20930493}
------------

A total of 57 women were assessed for eligibility, three failed to meet inclusion criteria and five declined to participate; accordingly, 49 participants were randomized and all of them completed the study (17 in HBG, 16 in PEG and 16 in CG) ([Figure 1](#fig1-1759720X20930493){ref-type="fig"}). The mean (SD) age for the participants was 53.30 (7.86) years, weight, 68.48 (14.34) kg and height, 1.61 (0.06) m. There were no statistically significant differences in age, weight or height between the three groups (*p* \> 0.05; data not shown). No incidents were reported during the interventions.

![Flowchart according to CONSORT Statement for the Report of randomized trials.\
CG, control group; HBG, hyperbaric Group; PEG, physical exercise group.](10.1177_1759720X20930493-fig1){#fig1-1759720X20930493}

Effects of the interventions {#section25-1759720X20930493}
----------------------------

A significant multivariate effect of the interaction between "group" and "treatment" was obtained \[F(32,64) = 2.29, *p* \< 0.05, η^[@bibr2-1759720X20930493]^ = 0.53\]. The significant differences and effect size among the pre- and post-treatment assessments (i.e. T0 and T1) for each group and each variable are shown in the following tables, as well as the differences between groups in each of the assessments.

The perceived pain, recorded by a VAS, significantly improved approximately 2.5 points in the HBG only, as opposed to what occurred in the PEG and CG (as noted in [Table 1](#table1-1759720X20930493){ref-type="table"}). However, results from the PPT assessment revealed that a significant improvement was achieved in the HBG only for the lateral epicondyle and gluteal points, while PEG achieved significant improvements in occiput, lower cervical area, second ribs, great trochanters and knees. CG failed to achieve a significant improvement in any of the pain-related variables (*p* \> 0.05). By contrast, the PPT assessment revealed a significant decrease of pain threshold in occiput, trapezius and supraspinatus.

###### 

Effect of the interventions on pain and pressure pain threshold.

![](10.1177_1759720X20930493-table1)

                                                  PEG           HBG               CG                                                                                        
  ----------------------------------------------- ------------- ----------------- ------------ ------------- ----------------- ------------ ------------- ----------------- ----------
  **VAS (cm)**                                    6.13 (2.22)   5.38 (2.16)                    7.35 (1.66)   **4.88 (2.32)**   1.06         5.63 (1.75)   5.5 (2.25)        
  **Occiput (kg.cm** ^--2^ **)**                  1.75 (0.94)   **2.18 (1.05)**   **--0.64**   1.56 (0.74)   1.66 (0.69)                    1.82 (0.38)   **1.37 (0.45)**   **0.68**
  **Lower Cervical muscles (kg.cm** ^--2^ **)**   1.05 (0.89)   **1.63 (0.91)**   **--0.98**   1.20 (0.63)   1.27 (0.64)                    1.36 (0.42)   1.12 (0.55)       
  **Trapezius (kg.cm** ^--2^ **)**                1.82 (0.95)   1.92 (0.68)                    1.70 (0.63)   1.86 (0.75)                    1.89 (0.71)   **1.55 (0.97)**   **0.56**
  **Supraspinatus (kg.cm** ^--2^ **)**            2.29 (1.24)   2.6 (1.45)                     1.89 (0.60)   2.13 (0.78)                    2.21 (0.93)   **1.74 (0.70)**   **0.57**
  **Second ribs (kg.cm** ^--2^ **)**              1.38 (1.11)   **1.79 (0.91)**   **--0.84**   1.61 (0.56)   1.8 (0.58)                     1.55 (0.41)   1.33 (0.67)       
  **Lateral epicondyle (kg.cm** ^--2^ **)**       1.35 (0.74)   1.57 (0.55)                    1.38 (0.33)   **1.75 (0.48)**   −0.69        1.48 (0.33)   1.24 (0.48)       
  **Gluteal muscles (kg.cm** ^--2^ **)**          2.55 (2.18)   2.72 (2.14)                    1.85 (0.84)   **2.28 (0.76)**   **--0.61**   2.00 (0.53)   1.68 (0.73)       
  **Greater trochanters (kg.cm** ^--2^ **)**      2.09 (1.25)   **2.51 (1.50)**   **--0.57**   1.84 (0.44)   2.12 (0.81)                    1.91 (0.80)   1.88 (0.76)       
  **Knees (kg.cm** ^--2^ **)**                    1.43 (0.81)   **1.97 (1.03)**   **--0.72**   1.74 (0.64)   2.02 (0.85)                    1.62 (0.62)   1.44 (0.76)       

Data are expressed as mean (SD).

CG, control group; d, Cohen's d effect size reported only when the differences were significant; HBG, Hyperbaric therapy group; PEG, Physical exercise group.

Bold type means statistically significant differences between pre- and post-treatment measurements (*p* \< 0.05).

Regarding the variables related to endurance and functional capacity, our results ([Table 2](#table2-1759720X20930493){ref-type="table"}) showed that a significant improvement of induced fatigue was achieved only in the HBG. Oxygen saturation and HR were not significantly influenced by any of the treatments received. Further, the distance achieved significantly improved with both low-pressure HBOT and physical exercise programs, although the size effect of the hyperbaric treatment was larger. The resting motor threshold slightly decreased in the PEG but achieved no significant threshold (the *p* value was 0.054). CG failed to achieve any significant improvement (*p* \> 0.05) in any of the endurance or functional capacity variables. In fact, HR was significantly poorer in this group.

###### 

Effect of interventions on endurance and functional capacity and resting motor threshold.

![](10.1177_1759720X20930493-table2)

                                                            Pre-treatment    Post-treatment       Effect size (d)
  --------------------------- ----------------------- ----- ---------------- -------------------- --------------------
                              **Induced Fatigue**     PEG   6.81 (2.64)      7.00 (2.48)          
                                                      HBG   7.94 (1.78)      **6.76 (2.14)**      **0.53**
                                                      CG    6.84 (2.05)      6.75 (2.62)          
  **6-minute walking test**   **Oxygen saturation**   PEG   97.25 (0.93)     97.75 (1.18)         
                                                      HBG   98.29 (0.92)     98.06 (0.83)         
                                                      CG    97.63 (1.36)     97.69 (1.08)         
                              **Heart rate**          PEG   111.38 (21.01)   113.56 (23.37)       
                                                      HBG   109.00 (17.64)   113.12 (19.7)        
                                                      CG    115.44 (15.14)   **127.75 (20.65)**   **--0.61**
                              **Distance**            PEG   481.00 (71.23)   **513.00 (64.84)**   **--0.75**
                                                      HBG   508.76 (62.71)   **558.29 (68.83)**   **--1.16**
                                                      CG    493.19 (68.48)   497.31 (76.29)       
                              **RMT**                 PEG   42.56 (9.38)     40.31 (5.68)         0.50 (*p* = 0.054)
                                                      HBG   39.76 (7.67)     38.35 (6.04)         
                                                      CG    45.25 (8.42)     45.19 (7.87)         

Data are expressed as mean (SD).

CG, control group; d, Cohen's d effect size reported only when the differences were significant; HBG, hyperbaric therapy group; PEG, physical exercise group; RMT, resting motor threshold.

Bold type means statistically significant differences between pre- and post-treatment measurements (*p* \< 0.05).

Finally, the SPPB score, related to physical performance, increased significantly in both treatments while remaining unchanged for CG ([Figure 2](#fig2-1759720X20930493){ref-type="fig"}). The difference in PEG was substantial mean (SE) of 1.4 (0.23) points, while moderate in HBG, specifically 0.89 (0.23) points in accordance with the classification of the differences reported by Perera *et al*.^[@bibr45-1759720X20930493]^

![Physical performance score in the studied groups before and after the interventions.\
Bars represent the mean and error bars, the standard deviation.\
CG, control group; HBG, hyperbaric therapy group; PEG, physical exercise group.](10.1177_1759720X20930493-fig2){#fig2-1759720X20930493}

Discussion {#section26-1759720X20930493}
==========

Our study has investigated the impact of low-pressure HBOT on induced fatigue, pain, endurance, functional capacity, physical performance and cortical excitability and compared the achieved results with those obtained following a low-intensity physical exercise protocol and with a control group. Low-pressure HBOT is shown to significantly reduce induced fatigue and to achieve significant improvements in perceived pain at rest and pressure pain threshold, although only in the lateral epicondyle and gluteal areas. Further, this therapy improved the endurance and functional capacity, and physical performance. On the contrary, the physical exercise program did not improve the perceived pain or induced fatigue, although significant improvements were obtained in the pressure pain thresholds of some of the tender points (i.e. occiput, low-cervical, second ribs, greater trochanters and knees) and this approach also improved the endurance and functional capacity and physical performance in a similar way, as did the low-pressure HBOT intervention.

Low-pressure HBOT significantly improved the feeling of fatigue after the completion of the 6MWT test (by 1.18 points). This may be due to an increased oxygen supply to the musculoskeletal system, which activates cellular activity (i.e. increases adenosine triphosphate synthesis) and promotes the metabolism of fatigue-related substances.^[@bibr46-1759720X20930493]^ Specifically, fatigue-associated metabolic factors produced during the process of contraction are hydrogen ions, lactate, inorganic phosphate, reactive oxygen species, heat shock protein and orosomucoid (reviewed in Wan *et al*.^[@bibr47-1759720X20930493]^), which may be better removed after applying an oxygen therapy. Indeed, it has been reported that HBOT reduces fatigue in chronic fatigue syndrome,^[@bibr20-1759720X20930493]^ which has been attributed to its ability to lower reactive oxygen species and acid lactic levels, and in muscle fatigue after exercise.^[@bibr21-1759720X20930493]^ However, this decreased fatigue was not found in PEG. These negative results are in line with those achieved in the study conducted by Giannotti *et al*. and Fontaine *et al*. who similarly failed to obtain significant improvements in the fatigue felt following the exercise intervention.^[@bibr48-1759720X20930493],[@bibr49-1759720X20930493]^ These findings support the effectiveness of HBOT, and not low-intensity physical exercise, to address fatigue in women with FM.

In addition, low pressure HBOT has achieved a significant decrease of 2.47 points in perceived pain. This could be due to the action of oxygen, which stimulates the growth of blood vessels and promotes tissue recovery, thus decreasing tissue hypoxia that causes pain.^[@bibr50-1759720X20930493][@bibr51-1759720X20930493][@bibr52-1759720X20930493]--[@bibr53-1759720X20930493]^ It may also cause a change in the brain pain-processing activity, due to changes in blood flow in the posterior and prefrontal regions of the brain.^[@bibr23-1759720X20930493]^ In addition, HBOT stimulates nitric oxide synthesis, which helps to alleviate hyperalgesia and NO-dependent release of endogenous opioids which has been proposed to be the primary HBOT mechanism of antinociception.^[@bibr54-1759720X20930493]^ This decrease in pain is in line with Yildiz's study,^[@bibr26-1759720X20930493]^ which used a similar treatment protocol, although with greater pressure than that applied in our study and which obtained significant improvements for pain scores in as much as 3.31 points. This confirms that, although the pressure applied in our study is lower than that used to date, which could avoid the aforementioned complications, it is sufficient to significantly reduce pain, with a result that exceeds 1 cm considered the minimum clinically relevant change.^[@bibr55-1759720X20930493],[@bibr56-1759720X20930493]^ However, the physical exercise program failed to improve the perceived pain (mean difference of 0.75 cm). The fact that no significant improvements have been found in the scores obtained in the VAS, as opposed to other studies,^[@bibr16-1759720X20930493],[@bibr48-1759720X20930493],[@bibr57-1759720X20930493],[@bibr58-1759720X20930493]^ may be due to poor physical exercise habits in these subjects, failing to adjust to the pace of the proposed physical exercise, which could cause excessive effort and thus a continued feeling of pain. However, the results of the pressure pain threshold at specific tender points showed a significantly greater impact of physical exercise compared with those obtained with hyperbaric treatment. While the perception of generalized pain takes into account the resulting pain, regardless of the trigger factor, when assessing the pain threshold at these tender points, the painful reaction to a mechanical stimulus, such as pressure, is specifically assessed. This response is influenced by muscle condition, which may have improved to a greater extent with the physical exercise program, as revealed by the size effect of the physical performance improvement, this being greater than that achieved with low-pressure HBOT, as discussed below. Low-pressure HBOT has improved the pain threshold at only two of the tender points, namely, the lateral epicondyle and the gluteal muscle, increasing the value by 0.37 and 0.43 kg/cm^2^, respectively. Nevertheless, the values obtained, although above the standard error of measurement, do not achieve the minimal detectable change (i.e. 0.54 kg/cm^2^)^[@bibr59-1759720X20930493]^ Studies by Efrati *et al*.^[@bibr23-1759720X20930493]^ Yildiz *et al*.^[@bibr26-1759720X20930493]^ reported that HBOT improved the pressure pain threshold, inducing an increase of between 1.07--1.14 kg/cm^2^ and 0.62 kg/cm^2^ respectively, although in both cases greater pressure was used. On the other hand, participants who followed a physical exercise program obtained significant improvements in the tender points of the occipital area, lower neck, second intercostal space, major trochanter and knees. These results are consistent with previous studies that have shown a beneficial effect of physical exercise on the pain threshold.^[@bibr60-1759720X20930493][@bibr61-1759720X20930493]--[@bibr62-1759720X20930493]^ As discussed above, improved muscle condition may help to improve the pain threshold under mechanical stimulation.^[@bibr63-1759720X20930493][@bibr64-1759720X20930493]--[@bibr65-1759720X20930493]^ In fact, poor fitness in women with FM is related to increased sensitivity to pain.^[@bibr66-1759720X20930493]^

Improvements were also obtained in endurance and functional capacity measured with the 6MWT test, where the HBG increased for the distance covered, with an average of 49.53 meters which exceeded the minimal clinically important difference, ranging from 14 to 35 m according to the review by Bohannon *et al*.^[@bibr67-1759720X20930493]^ These improvements could be due to enhanced tissue oxygenation produced by HBOT, which would accelerate the recovery of exercise-induced muscle damage.^[@bibr50-1759720X20930493]^ Indeed, O~2~ plays an essential role in cell metabolism and its availability is a main determinant of maximal O~2~ uptake^[@bibr68-1759720X20930493]^ which can be predicted by the 6MWT.^[@bibr69-1759720X20930493],[@bibr70-1759720X20930493]^ Similarly to HBG, PEG improved in endurance and functional capacity, increasing the distance covered by 32 meters. These improvements are due to the fact that PEG training directly affected the physical capacity of each participant, as it mainly consisted of aerobic training, combined with soft load and coordination exercises. These results are consistent with those reported by several authors showing improvements in endurance and functional capacity after physical exercise training in people with fibromyalgia.^[@bibr48-1759720X20930493],[@bibr57-1759720X20930493],[@bibr58-1759720X20930493],[@bibr71-1759720X20930493]^ Following the 6MWT test, no significant changes were observed in either HR or O~2~ saturation in either of the two experimental groups. By contrast, the CG revealed a significant HR increase of 12.31 pulsations after 8 weeks, which might be associated with the aggravated symptomatology in this group. In this regard, it has been proposed that there is a relationship between symptomatology and cardiorespiratory capacity,^[@bibr3-1759720X20930493]^ whereby the greater the symptomatology, the poorer the cardiorespiratory capacity.

Although SPPB was first designed for the elderly, it provides an appropriate level of challenge for many adults with chronic pain.^[@bibr72-1759720X20930493]^ For this reason, it has been used to evaluate physical performance, thus being able to objectify improvements for both HBG and PEG. Participants who underwent hyperbaric chamber treatment managed to significantly increase (0.89 points) the total score for this test, which implies an improvement in physical condition. This improvement may again be due to increased tissue perfusion,^[@bibr53-1759720X20930493]^ especially in muscles, which would lead to increased tissue regeneration,^[@bibr51-1759720X20930493],[@bibr52-1759720X20930493]^ increased oxygenation of damaged muscle structures and decreased swelling.^[@bibr50-1759720X20930493]^ This could lead to reduced pain and fatigue, which in turn could lead to better physical performance. No previous study using HBOT has evaluated physical performance, so the effects achieved in our study should not be compared with previous studies. With respect to women in PEG, they obtained an even greater improvement than those in HBG, according to the classification proposed by Perera, *et al*.^[@bibr45-1759720X20930493]^ PEG scores increased to 1.43 compared with 0.89 points in HBG, which could be due to the training program addressed in this study. A combined endurance and coordination protocol using work stations which consisted of 1 min exercise and 1 min rest, implying increased cardiac output, with changes in the pace and therefore constant cardiac training could generate adjustment to exertion^[@bibr73-1759720X20930493]^ and therefore present enhanced physical performance after the intervention.

Finally, cortical excitability has not improved with low pressure HBOT. This may be because low pressure HBOT does not directly affect M1, also known as Brodmann area 4, since, as explained by Efratti *et al*., the areas with most activity in the frontal lobe after HBOT measured by single photon emission computed tomography are: 25, 10, 47, 45, 11, 9, 8 and 38.^[@bibr23-1759720X20930493]^ The PEG likewise failed to achieve a significant improvement, although there was a trend (*p* = 0.054). As previously described, RMT in fibromyalgia patients is high. It has been proposed that this is due to the fact that the cortical excitability is altered and greater intensity is needed to achieve movement, which could be related to several underlying pathophysiological mechanisms of fibromyalgia^[@bibr9-1759720X20930493]^ including internal cortical dysfunction in the motor cortex,^[@bibr10-1759720X20930493]^ as well as poor patterns of movement or of cortical motor control.^[@bibr11-1759720X20930493]^ Slight, but not significant improvement in PEG may be due to the fact that it is the only treatment that directly affects movement control and may therefore influence the motor cortex after physical training as reported by other studies.^[@bibr74-1759720X20930493],[@bibr75-1759720X20930493]^ In fact, McDonnell's group concluded that only low-intensity exercise can effect changes in the motor cortex as in our study,^[@bibr76-1759720X20930493]^ which could explain the absence of significant results in other studies that used high-intensity aerobic exercise.^[@bibr77-1759720X20930493],[@bibr78-1759720X20930493]^ Further studies with a larger sample size are needed to ensure that the absence of significant differences are not due to a type II error.

To the best of our knowledge, this is the first experimental study comparing a treatment that requires physical exertion (i.e. physical exercise) against passive treatment (i.e. low pressure HBOT). Both treatments have been shown to be effective in terms of pain threshold, endurance, functional capacity and physical performance, with further improvements in HBG in the feeling of fatigue and perceived pain. By contrast, CG showed no improvements in any of the variables studied (*p* \> 0.05), and the PPT even dropped at three of the analysed tender points (i.e. occipital area, trapezius and supraspinatus) in addition to an increase in HR. Therefore, either treatment could be appropriate to improve the health condition in this population as symptomatology improved. However, given that the physical exercise does not decrease the subjective pain or the feeling of fatigue, unlike what happens with low pressure HBOT, this might lead to lower adherence to the physical exercise intervention.

Limitations {#section27-1759720X20930493}
-----------

The main limitation of the current study is the small sample size. Although our sample size calculation showed that our selected sample size was even larger than that required to obtain significant results, future studies should corroborate these findings with a larger sample size. Another limitation is that a follow-up measurement was not provided, which would have been of great interest to assess the durability of the treatment effects in chronic cases (i.e. the FM syndrome). Lastly, since FM syndrome mostly affects women, we included only women, and thus the gender effect has not been studied.

Conclusion {#section28-1759720X20930493}
==========

The results suggest that both low-pressure hyperbaric oxygen therapy and an 8-week program of low-impact physical exercise improve pain pressure threshold in some muscles at rest, endurance and functional capacity measured as the amount of distance walked, as well as physical performance in daily life activities. Induced fatigue and perceived pain at rest significantly improved only with low-pressure hyperbaric treatment. Thus, low-pressure hyperbaric oxygen treatment may be the treatment of choice in women with FM reporting high levels of pain and fatigue.
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